Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

References for PMC Articles for PubMed (Select 20143195)

1.

Multi-functional nanocarriers to overcome tumor drug resistance.

Jabr-Milane LS, van Vlerken LE, Yadav S, Amiji MM.

Cancer Treat Rev. 2008 Nov;34(7):592-602. doi: 10.1016/j.ctrv.2008.04.003. Epub 2008 Jun 5. Review.

2.

Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.

Devalapally H, Duan Z, Seiden MV, Amiji MM.

Clin Cancer Res. 2008 May 15;14(10):3193-203. doi: 10.1158/1078-0432.CCR-07-4973.

3.
4.

Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.

van Vlerken LE, Duan Z, Seiden MV, Amiji MM.

Cancer Res. 2007 May 15;67(10):4843-50.

6.

Targeting multidrug resistance in cancer.

Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM.

Nat Rev Drug Discov. 2006 Mar;5(3):219-34. Review.

PMID:
16518375
8.

Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines.

Little SR, Lynn DM, Ge Q, Anderson DG, Puram SV, Chen J, Eisen HN, Langer R.

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9534-9. Epub 2004 Jun 21.

9.

Multidrug resistance reversal agents.

Robert J, Jarry C.

J Med Chem. 2003 Nov 6;46(23):4805-17. Review. No abstract available.

PMID:
14584929
10.

The reversal of multidrug resistance: an update.

Kellen JA.

J Exp Ther Oncol. 2003 Jan-Feb;3(1):5-13. Review. No abstract available.

PMID:
12724854
11.
12.

Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.

Itoh M, Kitano T, Watanabe M, Kondo T, Yabu T, Taguchi Y, Iwai K, Tashima M, Uchiyama T, Okazaki T.

Clin Cancer Res. 2003 Jan;9(1):415-23.

13.

The therapeutic potential of modulating the ceramide/sphingomyelin pathway.

Kolesnick R.

J Clin Invest. 2002 Jul;110(1):3-8. Review. No abstract available.

14.

Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets.

Morjani H, Aouali N, Belhoussine R, Veldman RJ, Levade T, Manfait M.

Int J Cancer. 2001 Oct 15;94(2):157-65.

PMID:
11668492
16.

Ceramide glycosylation potentiates cellular multidrug resistance.

Liu YY, Han TY, Giuliano AE, Cabot MC.

FASEB J. 2001 Mar;15(3):719-30.

17.

Glucosylceramide: a marker for multiple-drug resistant cancers.

Lucci A, Cho WI, Han TY, Giuliano AE, Morton DL, Cabot MC.

Anticancer Res. 1998 Jan-Feb;18(1B):475-80.

PMID:
9568165
18.

Accumulation of glucosylceramides in multidrug-resistant cancer cells.

Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC.

J Biol Chem. 1996 Aug 9;271(32):19530-6.

19.

The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs.

Leonessa F, Boulay V, Wright A, Thompson EW, Brünner N, Clarke R.

Acta Oncol. 1992;31(2):115-23. Review.

PMID:
1622625
20.

Mechanisms of multidrug resistance in cancer treatment.

Harris AL, Hochhauser D.

Acta Oncol. 1992;31(2):205-13. Review.

PMID:
1352455
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk